In vivo and in vitro evaluation of a solid dispersion system of gliclazide:PEG 6000

PDA Journal of Pharmaceutical Science and Technology

Volumn 61, Issue 5, 2007, Pages 400-410

  Asyarie, Sukmadjaja ^a   Faizatun, ^a   Rachmawati, Heni ^a  

^a BANDUNG INSTITUTE OF TECHNOLOGY   (Indonesia)

Author keywords

Absorption; Dissolution in vitro; Gliclazide; Pharmacokinetic parameters; Solid dispersion

Indexed keywords

GLICLAZIDE; MACROGOL 6000;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DISSOLUTION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG SCREENING; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; EVAPORATION; GASTROINTESTINAL ABSORPTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROSCOPY; MALE; NONHUMAN; RAT; SINGLE DRUG DOSE; SOLID STATE; X RAY DIFFRACTION;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CRYSTALLOGRAPHY, X-RAY; DRUG CARRIERS; DRUG COMPOUNDING; GLICLAZIDE; HYDROGEN-ION CONCENTRATION; HYPOGLYCEMIC AGENTS; MALE; POLYETHYLENE GLYCOLS; POWDER DIFFRACTION; RATS; RATS, WISTAR; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TECHNOLOGY, PHARMACEUTICAL; WETTABILITY;

EID: 37349040343     PISSN: 10797440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kumar, V. S. G; Mishra, D. Preparation, characterization and dissolution studies of solid dispersion of meloxicam with PEG 6000. Yakugaku Zasshi 2006, 126 (8), 657-664.
2. Joshi, H. N.; Tejwani, R. W.; Davidovich, M.; Sahasrabudhe, V. P.; Jemal, M.; Bathala, M. S.; Varia, S. A.; Serajuddin, A. T. Bioavailability enhancement of a poorly water-soluble drug by solid dispersion in polyethylene glycol-polysorbate 80 mixture. Int. J. Pharm. 2004, 269 (1), 251-258.
3. Wassvik, C. M.; Holmen, A. G.; Bergstrom, C. A.; Zamora, I.; Artursson, P. Contribution of solid-state properties to the aqueous solubility of drugs. Eur. J. Pharm. Sci. 2006, 29 (3-4), 294-305.
4. Chokshi, R. J.; Zia, H.; Sandhu, H. K.; Shah, N. H.; Malick, W. A. Improving the dissolution rate of poorly water soluble drug by solid dispersion and solid solution. Drug Deliv. 2007, 14 (1), 33-45.
5. Palmer, K. J.; Brogden, R. N. Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus. Drugs 1993, 46 (1), 92-125.
6. Mailhot, J. Efficacy and safety of gliclazide in the treatment of non-insulin-dependent diabetes mellitus: a Canadian multicenter study. Clin. Ther. 1993, 15 (6), 1060-1068.
7. Harrower, A. D. Comparison of efficacy, secondary failure rate, and complications of sulfonylureas. J. Diabetes Complications 1994, 8 (4), 201-203.
8. Campbell, D. B.; Lavielle, R.; Nathan, C. The mode of action and clinical pharmacology of gliclazide: a review. Diabetes Res. Clin. Pract. 1991, 14 (Suppl 2), S21-36.
9. Deltrat, P.; Paraire, M.; Jochemsen, R. Complete bioavailability and lack of food-effect on pharmacokinetics of gliclazide 30 mg modified release in healthy volunteers. Biopharm. Drug Dispos. 2002, 23 (4), 151-157.
10. Chiou, W. L.; Riegelman, S. Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci. 1971, 60 (9), 1281-1302.
11. Park, J. Y.; Kim, K. A.; Kim, S. L.; Park, P. W. Quantification of gliclazide by semi-micro high-performance liquid chromatography: application to a bioequivalence study of two formulations in healthy subjects. J. Pharm. Biomed. Anal. 2004, 35 (4), 943-949.
12. Rachmawati, H.; Beljaars, L.; Reker-Smit, C.; Hagens, W. I.; Meijer, D. K. F.; Poelstra, K. Pharmacokinetic and biodistribution profile of recombinant human interleukin-10 in rats with extensive liver fibrosis. Pharm. Res. 2004, 21 (11), 2072-2078.
13. Yamashita, K.; Nakate, T.; Okimoto, K.; Ohike, A.; Tokunaga, Y.; Ibuki, R.; Higaki, K.; Kimura, T. Establishment of new preparation method for solid dispersion formulation of tacrolimus. Int. J. Pharm. 2003, 267 (1-2), 79-91.
14. Moyano, J. R.; Arias-Blanco, M. J.; Gines, J. M.; Giordano, F. Study of the complexation behaviour of gliclazide with partially methylated beta-cyclodextrin in solution and solid state. Int J. Pharm. 1997, 157 (2), 239-243.
15. Craig D. Q. M. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int. J. Pharm. 2002, 231 (2), 131-144 Artursson, P.
16. Ford, J. L. The current status of solid dispersions. Pharm. Acta Helv. 1986, 61 (3), 69-88.
17. Al-Angary, A. A.; Al-Mahrouk, G. M.; Al-Meshal, M. A. Interaction of polyethylene glycols with lorazepam. Pharm. Ind. 1996, 58 (3), 260-263.
18. Sjokvist Saers, E.; Craig, D. Q. M. An investigation into the mechanisms of dissolution of alkyl p-aminobenzoates from polyethylene glycol solid dispersion. Int. J. Pharm. 1992, 83 (1-3), 211-219.
19. Corrigan, O. I.; Timoney, R. F. The influence of polyethylene glycols on the dissolution properties of hydroflumethiazide. J.Pharm Pharmacol. 1976, 28 (9), 703-706.
20. Serajuddin, A. T. M., Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci. 1999, 88 (10), 1058-1066.